Refill Fees

How this component moves the total

Across the 20 priced programmes, all-in cost at a maintenance dose spans $145 to $324. Most published comparisons explain that spread as differences in the medicine. It is not: the molecule is identical and frequently comes from the same category of licensed pharmacy.

It is overhead, clinical wrap, pharmacy sourcing and margin — plus the component this page isolates, which is invisible in a single headline figure.

The comparison this makes possible

Once each component is priced separately, two programmes with the same advertised number stop looking equivalent. 4 of 20 charge a mandatory recurring fee; 19 hold one price at every dose. A programme scoring badly on both can advertise the same figure as one scoring well on both.

That is why every table here states all-in cost at a named dose rather than a headline, and why some of our figures are higher than a programme's own homepage.

What to take from this page

One number to carry into any intake conversation: what you will pay in month six at 2.4 mg, including every fee. On the cheapest verified route that is $145. Anything materially below that band, from anyone, deserves the question of which of the four distortions is producing it.

Charges that appear later

Isolating costs that surface after the first cycle is the only way two programmes with different structures become comparable. Without it you are ranking marketing decisions rather than costs.

The spread is not marginal. All-in cost at a 2.4 mg maintenance dose runs $145 to $324 across the 20 programmes we price — for the identical molecule, frequently from the same category of licensed pharmacy. Add the brand routes and the same active ingredient spans more than fifteenfold, from a roughly $149 oral option to a list price near $1,349.

The correction worth more than any negotiation: price the dose you expect to hold, add every recurring charge, and compare that figure. On the cheapest verified route it is $145 a month.

What a programme's answer here reveals

A programme that can state this component in one sentence has a simple structure and usually knows it is competitive. One that needs three sentences has a structure worth reading closely — not necessarily a worse deal, but a more conditional one.

One that cannot answer before an intake has made a commercial choice: it wants your contact details and a medical history before you can compare it against anything. That is legal and common, and it is why several programmes on this site carry a page explaining why we publish no figure for them.

Get the answer in writing. Almost every dispute in public complaint records for this category traces back to a number that was never put in an email.

The failure mode this section guards against

Choosing a programme on a number that describes a different situation than yours. An entry price when you will hold maintenance. A medication figure when a membership applies. A promotional rate when you will renew.

Each error is small alone and they compound in one direction, which is why the cheapest-looking option in most published comparisons is the one most likely to be mis-stated. Priced correctly the cheapest verified route sits at $145 a month all-in at a 2.4 mg maintenance dose.

Why we publish the working rather than a verdict

A single recommendation reads better and acts worse, because it hides the weighting. Two readers with different maintenance doses, different coverage and different tolerance for commitment should not receive the same answer.

So the tables carry the inputs and every ranking states its sort key. Disagree with our weighting and you can take the file and weight it yourself — which is what publishing it is for.

The number most people get wrong

The month-six figure. Almost everyone budgets from the first month, which on semaglutide describes four weeks at 0.25 mg — roughly 1 mg of active drug against the 9.6 mg a maintenance month delivers.

Ten of your first twelve months are spent at or near maintenance. A ranking sorted on the advertised month is sorting on about eight per cent of your year, and on a dose-scaled programme those are different numbers entirely.

Run the first-year calculator at the dose you expect to hold. It takes under a minute and it reorders the market for most people.

What a year of this actually looks like

Four weeks at 0.25 mg, four at 0.5 mg, four at 1 mg, four at 1.7 mg, then 2.4 mg for the remainder. Sixteen weeks of titration if nothing is repeated, and repeats are common rather than exceptional.

Budget two extra months at a lower tier and treat anything better as upside. Fix a weekly injection day, record dose and date, and diary the renewal date if an introductory rate applies — the reversion is where most complaints in this category begin.

How much refill fees should weigh

Less than the dose question and more than the brand. 19 of 20 programmes hold one price from 0.25 mg to 2.4 mg; the rest reprice as you climb. Which group you choose changes a twelve-month total more than almost any other single decision.

That is because semaglutide titrates slowly. Sixteen weeks minimum to a maintenance dose, frequently longer for tolerability, and a dose-scaled programme reprices you at every step of it.

Flat pricing is worst value at the bottom of the ladder and best at the top, which makes it less a lower price than insurance against a decision your prescriber has not made yet.

What a well-run programme publishes

Its price at every strength. Its pharmacy. Its prescriber's licensure. Its cancellation notice period. And which form of the active ingredient it compounds from, because FDA has distinguished semaglutide base from salt forms and linked the salts to safety concerns.

That last one is specific to this molecule and almost never asked. Programmes that answer it precisely are telling you how closely they supervise their supply chain.